nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—ABCB1—Parkinson's disease	0.367	1	CbGaD
Arsenic trioxide—MAPK3—adrenal medulla—Parkinson's disease	0.022	0.0981	CbGeAlD
Arsenic trioxide—AKT1—adrenal medulla—Parkinson's disease	0.0207	0.0925	CbGeAlD
Arsenic trioxide—JUN—adrenal medulla—Parkinson's disease	0.018	0.0805	CbGeAlD
Arsenic trioxide—AKT1—forelimb—Parkinson's disease	0.00953	0.0425	CbGeAlD
Arsenic trioxide—JUN—peripheral nervous system—Parkinson's disease	0.00582	0.026	CbGeAlD
Arsenic trioxide—AKT1—nerve—Parkinson's disease	0.00521	0.0233	CbGeAlD
Arsenic trioxide—MAPK1—hindbrain—Parkinson's disease	0.00468	0.0209	CbGeAlD
Arsenic trioxide—JUN—nerve—Parkinson's disease	0.00454	0.0203	CbGeAlD
Arsenic trioxide—AKT1—hindbrain—Parkinson's disease	0.0039	0.0174	CbGeAlD
Arsenic trioxide—CCND1—embryo—Parkinson's disease	0.00347	0.0155	CbGeAlD
Arsenic trioxide—JUN—hindbrain—Parkinson's disease	0.0034	0.0152	CbGeAlD
Arsenic trioxide—CCND1—forebrain—Parkinson's disease	0.00307	0.0137	CbGeAlD
Arsenic trioxide—MAPK1—embryo—Parkinson's disease	0.00293	0.0131	CbGeAlD
Arsenic trioxide—MAPK1—brainstem—Parkinson's disease	0.00268	0.012	CbGeAlD
Arsenic trioxide—CCND1—cardiovascular system—Parkinson's disease	0.0026	0.0116	CbGeAlD
Arsenic trioxide—MAPK3—embryo—Parkinson's disease	0.00259	0.0116	CbGeAlD
Arsenic trioxide—MAPK1—forebrain—Parkinson's disease	0.00259	0.0115	CbGeAlD
Arsenic trioxide—AKT1—embryo—Parkinson's disease	0.00244	0.0109	CbGeAlD
Arsenic trioxide—TXNRD1—forebrain—Parkinson's disease	0.00241	0.0108	CbGeAlD
Arsenic trioxide—MAPK3—forebrain—Parkinson's disease	0.00229	0.0102	CbGeAlD
Arsenic trioxide—AKT1—brainstem—Parkinson's disease	0.00224	0.00999	CbGeAlD
Arsenic trioxide—CCND1—medulla oblongata—Parkinson's disease	0.00222	0.0099	CbGeAlD
Arsenic trioxide—MAPK1—cardiovascular system—Parkinson's disease	0.00219	0.00977	CbGeAlD
Arsenic trioxide—AKT1—forebrain—Parkinson's disease	0.00216	0.00964	CbGeAlD
Arsenic trioxide—JUN—embryo—Parkinson's disease	0.00213	0.00949	CbGeAlD
Arsenic trioxide—IKBKB—embryo—Parkinson's disease	0.00212	0.00944	CbGeAlD
Arsenic trioxide—TXNRD1—cardiovascular system—Parkinson's disease	0.00204	0.00909	CbGeAlD
Arsenic trioxide—CCND1—midbrain—Parkinson's disease	0.00203	0.00905	CbGeAlD
Arsenic trioxide—CCND1—spinal cord—Parkinson's disease	0.00198	0.00883	CbGeAlD
Arsenic trioxide—JUN—brainstem—Parkinson's disease	0.00195	0.00869	CbGeAlD
Arsenic trioxide—MAPK3—cardiovascular system—Parkinson's disease	0.00194	0.00864	CbGeAlD
Arsenic trioxide—JUN—forebrain—Parkinson's disease	0.00188	0.00839	CbGeAlD
Arsenic trioxide—AKT1—cardiovascular system—Parkinson's disease	0.00183	0.00815	CbGeAlD
Arsenic trioxide—CCND1—head—Parkinson's disease	0.00176	0.00785	CbGeAlD
Arsenic trioxide—TXNRD1—medulla oblongata—Parkinson's disease	0.00174	0.00777	CbGeAlD
Arsenic trioxide—MAPK1—spinal cord—Parkinson's disease	0.00167	0.00744	CbGeAlD
Arsenic trioxide—CCND1—nervous system—Parkinson's disease	0.00167	0.00744	CbGeAlD
Arsenic trioxide—MAPK3—medulla oblongata—Parkinson's disease	0.00165	0.00739	CbGeAlD
Arsenic trioxide—CCND1—central nervous system—Parkinson's disease	0.00161	0.00716	CbGeAlD
Arsenic trioxide—TXNRD1—midbrain—Parkinson's disease	0.00159	0.0071	CbGeAlD
Arsenic trioxide—JUN—cardiovascular system—Parkinson's disease	0.00159	0.00709	CbGeAlD
Arsenic trioxide—IKBKB—cardiovascular system—Parkinson's disease	0.00158	0.00706	CbGeAlD
Arsenic trioxide—CCND1—cerebellum—Parkinson's disease	0.00157	0.007	CbGeAlD
Arsenic trioxide—AKT1—medulla oblongata—Parkinson's disease	0.00156	0.00696	CbGeAlD
Arsenic trioxide—TXNRD1—spinal cord—Parkinson's disease	0.00155	0.00693	CbGeAlD
Arsenic trioxide—MAPK3—midbrain—Parkinson's disease	0.00151	0.00675	CbGeAlD
Arsenic trioxide—MAPK1—head—Parkinson's disease	0.00148	0.00661	CbGeAlD
Arsenic trioxide—MAPK3—spinal cord—Parkinson's disease	0.00148	0.00659	CbGeAlD
Arsenic trioxide—AKT1—midbrain—Parkinson's disease	0.00143	0.00637	CbGeAlD
Arsenic trioxide—MAPK1—nervous system—Parkinson's disease	0.0014	0.00627	CbGeAlD
Arsenic trioxide—AKT1—spinal cord—Parkinson's disease	0.00139	0.00621	CbGeAlD
Arsenic trioxide—TXNRD1—head—Parkinson's disease	0.00138	0.00616	CbGeAlD
Arsenic trioxide—JUN—medulla oblongata—Parkinson's disease	0.00136	0.00606	CbGeAlD
Arsenic trioxide—MAPK1—central nervous system—Parkinson's disease	0.00135	0.00604	CbGeAlD
Arsenic trioxide—MAPK1—cerebellum—Parkinson's disease	0.00132	0.0059	CbGeAlD
Arsenic trioxide—MAPK3—head—Parkinson's disease	0.00131	0.00585	CbGeAlD
Arsenic trioxide—TXNRD1—nervous system—Parkinson's disease	0.00131	0.00584	CbGeAlD
Arsenic trioxide—CCND1—brain—Parkinson's disease	0.00127	0.00569	CbGeAlD
Arsenic trioxide—TXNRD1—central nervous system—Parkinson's disease	0.00126	0.00562	CbGeAlD
Arsenic trioxide—MAPK3—nervous system—Parkinson's disease	0.00124	0.00555	CbGeAlD
Arsenic trioxide—JUN—midbrain—Parkinson's disease	0.00124	0.00554	CbGeAlD
Arsenic trioxide—AKT1—head—Parkinson's disease	0.00124	0.00552	CbGeAlD
Arsenic trioxide—TXNRD1—cerebellum—Parkinson's disease	0.00123	0.00549	CbGeAlD
Arsenic trioxide—JUN—spinal cord—Parkinson's disease	0.00121	0.00541	CbGeAlD
Arsenic trioxide—MAPK3—central nervous system—Parkinson's disease	0.0012	0.00534	CbGeAlD
Arsenic trioxide—AKT1—nervous system—Parkinson's disease	0.00117	0.00523	CbGeAlD
Arsenic trioxide—MAPK3—cerebellum—Parkinson's disease	0.00117	0.00522	CbGeAlD
Arsenic trioxide—AKT1—central nervous system—Parkinson's disease	0.00113	0.00504	CbGeAlD
Arsenic trioxide—AKT1—cerebellum—Parkinson's disease	0.0011	0.00492	CbGeAlD
Arsenic trioxide—JUN—head—Parkinson's disease	0.00108	0.0048	CbGeAlD
Arsenic trioxide—MAPK1—brain—Parkinson's disease	0.00107	0.00479	CbGeAlD
Arsenic trioxide—IKBKB—head—Parkinson's disease	0.00107	0.00478	CbGeAlD
Arsenic trioxide—JUN—nervous system—Parkinson's disease	0.00102	0.00455	CbGeAlD
Arsenic trioxide—IKBKB—nervous system—Parkinson's disease	0.00102	0.00453	CbGeAlD
Arsenic trioxide—TXNRD1—brain—Parkinson's disease	0.000999	0.00446	CbGeAlD
Arsenic trioxide—JUN—central nervous system—Parkinson's disease	0.000983	0.00439	CbGeAlD
Arsenic trioxide—IKBKB—central nervous system—Parkinson's disease	0.000978	0.00436	CbGeAlD
Arsenic trioxide—JUN—cerebellum—Parkinson's disease	0.00096	0.00429	CbGeAlD
Arsenic trioxide—IKBKB—cerebellum—Parkinson's disease	0.000956	0.00427	CbGeAlD
Arsenic trioxide—MAPK3—brain—Parkinson's disease	0.00095	0.00424	CbGeAlD
Arsenic trioxide—AKT1—brain—Parkinson's disease	0.000896	0.004	CbGeAlD
Arsenic trioxide—CYP1B1—cardiovascular system—Parkinson's disease	0.000847	0.00378	CbGeAlD
Arsenic trioxide—JUN—brain—Parkinson's disease	0.00078	0.00348	CbGeAlD
Arsenic trioxide—IKBKB—brain—Parkinson's disease	0.000776	0.00346	CbGeAlD
Arsenic trioxide—CYP1B1—head—Parkinson's disease	0.000574	0.00256	CbGeAlD
Arsenic trioxide—CYP1B1—nervous system—Parkinson's disease	0.000544	0.00243	CbGeAlD
Arsenic trioxide—CYP1B1—central nervous system—Parkinson's disease	0.000524	0.00234	CbGeAlD
Arsenic trioxide—CYP1B1—cerebellum—Parkinson's disease	0.000512	0.00229	CbGeAlD
Arsenic trioxide—ABCB1—embryo—Parkinson's disease	0.000416	0.00186	CbGeAlD
Arsenic trioxide—CYP1B1—brain—Parkinson's disease	0.000416	0.00186	CbGeAlD
Arsenic trioxide—CYP1A1—head—Parkinson's disease	0.000406	0.00181	CbGeAlD
Arsenic trioxide—CYP1A1—nervous system—Parkinson's disease	0.000385	0.00172	CbGeAlD
Arsenic trioxide—CYP1A1—central nervous system—Parkinson's disease	0.00037	0.00165	CbGeAlD
Arsenic trioxide—ABCB1—forebrain—Parkinson's disease	0.000368	0.00164	CbGeAlD
Arsenic trioxide—ABCB1—cardiovascular system—Parkinson's disease	0.000311	0.00139	CbGeAlD
Arsenic trioxide—CYP1A1—brain—Parkinson's disease	0.000294	0.00131	CbGeAlD
Arsenic trioxide—CYP3A4—nervous system—Parkinson's disease	0.000282	0.00126	CbGeAlD
Arsenic trioxide—CYP3A4—central nervous system—Parkinson's disease	0.000272	0.00121	CbGeAlD
Arsenic trioxide—ABCB1—medulla oblongata—Parkinson's disease	0.000266	0.00119	CbGeAlD
Arsenic trioxide—ABCB1—midbrain—Parkinson's disease	0.000243	0.00108	CbGeAlD
Arsenic trioxide—ABCB1—spinal cord—Parkinson's disease	0.000237	0.00106	CbGeAlD
Arsenic trioxide—ABCB1—head—Parkinson's disease	0.000211	0.00094	CbGeAlD
Arsenic trioxide—ABCB1—nervous system—Parkinson's disease	0.0002	0.000892	CbGeAlD
Arsenic trioxide—ABCB1—central nervous system—Parkinson's disease	0.000192	0.000858	CbGeAlD
Arsenic trioxide—ABCB1—cerebellum—Parkinson's disease	0.000188	0.000839	CbGeAlD
Arsenic trioxide—ABCB1—brain—Parkinson's disease	0.000153	0.000682	CbGeAlD
Arsenic trioxide—MAPK3—Signaling Pathways—FGB—Parkinson's disease	1.94e-05	4.76e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—DRD3—Parkinson's disease	1.94e-05	4.75e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—HTR2A—Parkinson's disease	1.94e-05	4.75e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—ABL1—Parkinson's disease	1.94e-05	4.75e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—HTR1A—Parkinson's disease	1.93e-05	4.73e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—DRD1—Parkinson's disease	1.93e-05	4.71e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—CYP2D6—Parkinson's disease	1.91e-05	4.69e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by NGF—IL6—Parkinson's disease	1.91e-05	4.67e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—HGF—Parkinson's disease	1.91e-05	4.66e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TAC1—Parkinson's disease	1.9e-05	4.66e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—DDC—Parkinson's disease	1.88e-05	4.61e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cytokine Signaling in Immune system—IL6—Parkinson's disease	1.88e-05	4.61e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—CTGF—Parkinson's disease	1.88e-05	4.6e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular responses to stress—IL6—Parkinson's disease	1.88e-05	4.6e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—INSR—Parkinson's disease	1.87e-05	4.58e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—DRD1—Parkinson's disease	1.87e-05	4.57e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—DRD3—Parkinson's disease	1.86e-05	4.57e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by NGF—IL6—Parkinson's disease	1.85e-05	4.53e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—FGB—Parkinson's disease	1.85e-05	4.53e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—HTR2A—Parkinson's disease	1.85e-05	4.52e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—HTR1A—Parkinson's disease	1.84e-05	4.5e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	1.84e-05	4.5e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—HGF—Parkinson's disease	1.82e-05	4.46e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—ADRBK1—Parkinson's disease	1.81e-05	4.44e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TAC1—Parkinson's disease	1.81e-05	4.44e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—DRD3—Parkinson's disease	1.81e-05	4.43e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	1.79e-05	4.39e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—IL6—Parkinson's disease	1.79e-05	4.39e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GSTA4—Parkinson's disease	1.78e-05	4.36e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—DRD1—Parkinson's disease	1.78e-05	4.35e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—MAPK8—Parkinson's disease	1.77e-05	4.34e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—FGB—Parkinson's disease	1.77e-05	4.33e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by NGF—IL6—Parkinson's disease	1.76e-05	4.31e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—HTR1A—Parkinson's disease	1.76e-05	4.31e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.76e-05	4.3e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—DRD2—Parkinson's disease	1.76e-05	4.3e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—HTR7—Parkinson's disease	1.76e-05	4.3e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—CYP2E1—Parkinson's disease	1.75e-05	4.29e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—COMT—Parkinson's disease	1.75e-05	4.27e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—ADRBK1—Parkinson's disease	1.74e-05	4.26e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—GSTP1—Parkinson's disease	1.74e-05	4.25e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TAC1—Parkinson's disease	1.73e-05	4.24e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—MAOA—Parkinson's disease	1.73e-05	4.24e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—NQO1—Parkinson's disease	1.73e-05	4.24e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—DRD3—Parkinson's disease	1.72e-05	4.21e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	1.72e-05	4.21e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—IL6—Parkinson's disease	1.71e-05	4.2e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—HMOX1—Parkinson's disease	1.71e-05	4.19e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—TH—Parkinson's disease	1.71e-05	4.18e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—MAPK8—Parkinson's disease	1.7e-05	4.17e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—DRD1—Parkinson's disease	1.7e-05	4.16e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—ADRBK1—Parkinson's disease	1.69e-05	4.13e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	1.69e-05	4.13e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—HTR7—Parkinson's disease	1.69e-05	4.13e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—DRD2—Parkinson's disease	1.69e-05	4.13e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by NGF—IL6—Parkinson's disease	1.69e-05	4.13e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—MTHFR—Parkinson's disease	1.68e-05	4.12e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Axon guidance—IL6—Parkinson's disease	1.68e-05	4.1e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ND3—Parkinson's disease	1.67e-05	4.08e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—MCCC1—Parkinson's disease	1.67e-05	4.08e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—MAPK8—Parkinson's disease	1.65e-05	4.05e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—DRD3—Parkinson's disease	1.65e-05	4.03e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—ABCB1—Parkinson's disease	1.64e-05	4.03e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—CYCS—Parkinson's disease	1.64e-05	4.01e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—DRD2—Parkinson's disease	1.64e-05	4e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—HTR7—Parkinson's disease	1.64e-05	4e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—MTHFR—Parkinson's disease	1.63e-05	4e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ADRBK1—Parkinson's disease	1.61e-05	3.93e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PLA2G6—Parkinson's disease	1.6e-05	3.92e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—GSTM1—Parkinson's disease	1.6e-05	3.91e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Axon guidance—IL6—Parkinson's disease	1.59e-05	3.9e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—MAOB—Parkinson's disease	1.59e-05	3.88e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—MAPK8—Parkinson's disease	1.57e-05	3.85e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—APOE—Parkinson's disease	1.57e-05	3.84e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—TALDO1—Parkinson's disease	1.57e-05	3.84e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—OMD—Parkinson's disease	1.57e-05	3.84e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—DRD2—Parkinson's disease	1.56e-05	3.81e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—HTR7—Parkinson's disease	1.56e-05	3.81e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—MTHFR—Parkinson's disease	1.55e-05	3.81e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ADRBK1—Parkinson's disease	1.54e-05	3.76e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—GPX1—Parkinson's disease	1.53e-05	3.74e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—TNF—Parkinson's disease	1.53e-05	3.74e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—CASP3—Parkinson's disease	1.52e-05	3.72e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—APOE—Parkinson's disease	1.52e-05	3.72e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.51e-05	3.7e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—MAPK8—Parkinson's disease	1.51e-05	3.68e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—DDC—Parkinson's disease	1.51e-05	3.68e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.5e-05	3.66e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—HTR7—Parkinson's disease	1.49e-05	3.65e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—DRD2—Parkinson's disease	1.49e-05	3.65e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	1.49e-05	3.64e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—TNF—Parkinson's disease	1.48e-05	3.63e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IGF2—Parkinson's disease	1.47e-05	3.6e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—COMT—Parkinson's disease	1.45e-05	3.55e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—APOE—Parkinson's disease	1.45e-05	3.54e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—GSTP1—Parkinson's disease	1.44e-05	3.53e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—MAOA—Parkinson's disease	1.44e-05	3.53e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—HMOX1—Parkinson's disease	1.42e-05	3.49e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IGF1R—Parkinson's disease	1.42e-05	3.48e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GSTA4—Parkinson's disease	1.42e-05	3.48e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GCH1—Parkinson's disease	1.42e-05	3.47e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IGF2—Parkinson's disease	1.41e-05	3.46e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—MTHFR—Parkinson's disease	1.41e-05	3.45e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—TNF—Parkinson's disease	1.41e-05	3.45e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—EDN1—Parkinson's disease	1.41e-05	3.44e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—MAPK8—Parkinson's disease	1.4e-05	3.42e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IGF2—Parkinson's disease	1.37e-05	3.36e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—ABCB1—Parkinson's disease	1.37e-05	3.35e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IGF1R—Parkinson's disease	1.37e-05	3.35e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—EDN1—Parkinson's disease	1.35e-05	3.31e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—INS—Parkinson's disease	1.34e-05	3.28e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	1.34e-05	3.27e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—GSTM1—Parkinson's disease	1.33e-05	3.25e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IGF1R—Parkinson's disease	1.33e-05	3.24e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—APOE—Parkinson's disease	1.31e-05	3.22e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—EDN1—Parkinson's disease	1.31e-05	3.21e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IGF2—Parkinson's disease	1.3e-05	3.19e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—INS—Parkinson's disease	1.3e-05	3.18e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—NGF—Parkinson's disease	1.29e-05	3.16e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PLA2G6—Parkinson's disease	1.28e-05	3.13e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—GPX1—Parkinson's disease	1.27e-05	3.11e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—MAOB—Parkinson's disease	1.27e-05	3.1e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GBA—Parkinson's disease	1.26e-05	3.09e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—DBH—Parkinson's disease	1.26e-05	3.09e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.26e-05	3.09e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IGF1R—Parkinson's disease	1.26e-05	3.09e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IGF2—Parkinson's disease	1.25e-05	3.05e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—EDN1—Parkinson's disease	1.25e-05	3.05e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—NGF—Parkinson's disease	1.24e-05	3.04e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—INS—Parkinson's disease	1.24e-05	3.03e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—IL6—Parkinson's disease	1.23e-05	3.02e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—HTR2A—Parkinson's disease	1.23e-05	3.01e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IGF1R—Parkinson's disease	1.21e-05	2.95e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—NGF—Parkinson's disease	1.2e-05	2.95e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—IL6—Parkinson's disease	1.2e-05	2.93e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—EDN1—Parkinson's disease	1.19e-05	2.92e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—HTR2A—Parkinson's disease	1.18e-05	2.89e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CYP2D6—Parkinson's disease	1.18e-05	2.89e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—MTHFR—Parkinson's disease	1.17e-05	2.87e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CTGF—Parkinson's disease	1.16e-05	2.83e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—HTR2A—Parkinson's disease	1.15e-05	2.8e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—NGF—Parkinson's disease	1.15e-05	2.8e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—APOE—Parkinson's disease	1.14e-05	2.8e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—IL6—Parkinson's disease	1.14e-05	2.78e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—IL6—Parkinson's disease	1.13e-05	2.77e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL1B—Parkinson's disease	1.13e-05	2.76e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—INS—Parkinson's disease	1.12e-05	2.75e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—APOE—Parkinson's disease	1.1e-05	2.69e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—NGF—Parkinson's disease	1.1e-05	2.68e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—APOE—Parkinson's disease	1.09e-05	2.67e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—HTR2A—Parkinson's disease	1.09e-05	2.67e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—IL6—Parkinson's disease	1.09e-05	2.66e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL1B—Parkinson's disease	1.08e-05	2.65e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CYP2E1—Parkinson's disease	1.08e-05	2.64e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—NQO1—Parkinson's disease	1.07e-05	2.61e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—APOE—Parkinson's disease	1.07e-05	2.61e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—IL6—Parkinson's disease	1.06e-05	2.58e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—TH—Parkinson's disease	1.05e-05	2.57e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL1B—Parkinson's disease	1.05e-05	2.57e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—HTR2A—Parkinson's disease	1.04e-05	2.55e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—MAPK8—Parkinson's disease	1.03e-05	2.53e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—APOE—Parkinson's disease	1.01e-05	2.48e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CYCS—Parkinson's disease	1.01e-05	2.47e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—IL6—Parkinson's disease	1e-05	2.46e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL1B—Parkinson's disease	9.99e-06	2.45e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—MAPK8—Parkinson's disease	9.93e-06	2.43e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—INS—Parkinson's disease	9.76e-06	2.39e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—APOE—Parkinson's disease	9.7e-06	2.37e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—MAPK8—Parkinson's disease	9.63e-06	2.36e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—IL6—Parkinson's disease	9.61e-06	2.35e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL1B—Parkinson's disease	9.56e-06	2.34e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CYP2D6—Parkinson's disease	9.42e-06	2.31e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—INS—Parkinson's disease	9.38e-06	2.3e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—INS—Parkinson's disease	9.33e-06	2.28e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—DDC—Parkinson's disease	9.27e-06	2.27e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CTGF—Parkinson's disease	9.24e-06	2.26e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—MAPK8—Parkinson's disease	9.16e-06	2.24e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—INS—Parkinson's disease	9.1e-06	2.23e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—COMT—Parkinson's disease	8.93e-06	2.19e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—IL6—Parkinson's disease	8.93e-06	2.19e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GSTP1—Parkinson's disease	8.89e-06	2.18e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—MAOA—Parkinson's disease	8.87e-06	2.17e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—HMOX1—Parkinson's disease	8.77e-06	2.15e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—MAPK8—Parkinson's disease	8.77e-06	2.15e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GSTA4—Parkinson's disease	8.76e-06	2.14e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—INS—Parkinson's disease	8.66e-06	2.12e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CYP2E1—Parkinson's disease	8.61e-06	2.11e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—NQO1—Parkinson's disease	8.52e-06	2.08e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ABCB1—Parkinson's disease	8.42e-06	2.06e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—TH—Parkinson's disease	8.39e-06	2.05e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—INS—Parkinson's disease	8.28e-06	2.03e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GSTM1—Parkinson's disease	8.17e-06	2e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CYCS—Parkinson's disease	8.06e-06	1.97e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	7.89e-06	1.93e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GPX1—Parkinson's disease	7.83e-06	1.92e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—MAOB—Parkinson's disease	7.81e-06	1.91e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CASP3—Parkinson's disease	7.27e-06	1.78e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—MTHFR—Parkinson's disease	7.22e-06	1.77e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—COMT—Parkinson's disease	7.14e-06	1.75e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GSTP1—Parkinson's disease	7.1e-06	1.74e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—MAOA—Parkinson's disease	7.09e-06	1.73e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—HMOX1—Parkinson's disease	7e-06	1.71e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CASP3—Parkinson's disease	6.98e-06	1.71e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—IL6—Parkinson's disease	6.94e-06	1.7e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CASP3—Parkinson's disease	6.77e-06	1.66e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—IL6—Parkinson's disease	6.73e-06	1.65e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—APOE—Parkinson's disease	6.72e-06	1.65e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MAPK8—Parkinson's disease	6.68e-06	1.64e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL6—Parkinson's disease	6.6e-06	1.62e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GSTM1—Parkinson's disease	6.53e-06	1.6e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CASP3—Parkinson's disease	6.45e-06	1.58e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MAPK8—Parkinson's disease	6.42e-06	1.57e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—IL6—Parkinson's disease	6.4e-06	1.57e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL6—Parkinson's disease	6.34e-06	1.55e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GPX1—Parkinson's disease	6.25e-06	1.53e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MAPK8—Parkinson's disease	6.23e-06	1.52e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CASP3—Parkinson's disease	6.17e-06	1.51e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL6—Parkinson's disease	6.15e-06	1.51e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MAPK8—Parkinson's disease	5.92e-06	1.45e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—IL6—Parkinson's disease	5.85e-06	1.43e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL6—Parkinson's disease	5.85e-06	1.43e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	5.8e-06	1.42e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—MTHFR—Parkinson's disease	5.77e-06	1.41e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—INS—Parkinson's disease	5.74e-06	1.41e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CTGF—Parkinson's disease	5.69e-06	1.39e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—IL6—Parkinson's disease	5.68e-06	1.39e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MAPK8—Parkinson's disease	5.67e-06	1.39e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL6—Parkinson's disease	5.6e-06	1.37e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—IL6—Parkinson's disease	5.4e-06	1.32e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—APOE—Parkinson's disease	5.37e-06	1.31e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	5.31e-06	1.3e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—NQO1—Parkinson's disease	5.25e-06	1.28e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—TH—Parkinson's disease	5.17e-06	1.27e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYCS—Parkinson's disease	4.96e-06	1.22e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—INS—Parkinson's disease	4.59e-06	1.12e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—COMT—Parkinson's disease	4.4e-06	1.08e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GSTP1—Parkinson's disease	4.38e-06	1.07e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—MAOA—Parkinson's disease	4.37e-06	1.07e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—HMOX1—Parkinson's disease	4.32e-06	1.06e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL6—Parkinson's disease	4.27e-06	1.04e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ABCB1—Parkinson's disease	4.14e-06	1.01e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL6—Parkinson's disease	4.1e-06	1e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GSTM1—Parkinson's disease	4.02e-06	9.84e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL6—Parkinson's disease	3.98e-06	9.73e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GPX1—Parkinson's disease	3.85e-06	9.43e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL6—Parkinson's disease	3.78e-06	9.26e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL6—Parkinson's disease	3.62e-06	8.86e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—MTHFR—Parkinson's disease	3.55e-06	8.7e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—APOE—Parkinson's disease	3.31e-06	8.1e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—INS—Parkinson's disease	2.83e-06	6.92e-06	CbGpPWpGaD
